Kennedy Capital Management LLC lowered its stake in Danaher Corporation (NYSE:DHR – Free Report) by 13.2% in the second quarter, Holdings Channel.com reports. The institutional investor owned 41,336 shares of the conglomerate’s stock after selling 6,292 shares during the quarter. Kennedy Capital Management LLC’s holdings in Danaher were worth $8,166,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Red Tortoise LLC grew its position in Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after acquiring an additional 98 shares in the last quarter. Ramirez Asset Management Inc. purchased a new position in shares of Danaher in the second quarter valued at $40,000. Costello Asset Management INC acquired a new stake in Danaher during the 1st quarter valued at $41,000. Twin Peaks Wealth Advisors LLC purchased a new stake in Danaher during the 2nd quarter worth $51,000. Finally, Strengthening Families & Communities LLC lifted its holdings in Danaher by 81.4% in the 1st quarter. Strengthening Families & Communities LLC now owns 254 shares of the conglomerate’s stock worth $52,000 after buying an additional 114 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Danaher news, Director Teri List sold 3,298 shares of the firm’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the transaction, the director owned 20,762 shares of the company’s stock, valued at $4,702,593. This trade represents a 13.71% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Georgeann Couchara sold 5,174 shares of Danaher stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $210.42, for a total value of $1,088,713.08. Following the completion of the transaction, the senior vice president owned 2,625 shares of the company’s stock, valued at approximately $552,352.50. The trade was a 66.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 30,248 shares of company stock worth $6,609,663 over the last quarter. 11.10% of the stock is owned by company insiders.
Danaher Price Performance
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the previous year, the company posted $1.71 earnings per share. The firm’s revenue was up 4.4% on a year-over-year basis. As a group, equities research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.
Danaher Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Investors of record on Friday, September 26th were given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend was Friday, September 26th. Danaher’s dividend payout ratio is currently 26.39%.
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on the company. Evercore ISI lifted their target price on Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Royal Bank Of Canada set a $241.00 price objective on Danaher in a research note on Tuesday, September 2nd. Rothschild Redb lowered Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. Robert W. Baird set a $247.00 price target on shares of Danaher in a research report on Wednesday, October 22nd. Finally, Wells Fargo & Company restated a “positive” rating on shares of Danaher in a research note on Thursday, October 23rd. Twenty analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus target price of $245.75.
View Our Latest Stock Report on DHR
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Recommended Stories
- Five stocks we like better than Danaher
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Could Ross Stores Stock Hit $200 by Christmas? Here Are 3 Reasons Analysts Think So
- How to buy stock: A step-by-step guide for beginners
- The Trade Desk: After a 70% Plunge, This Could Be The Time to Buy
- What is an Earnings Surprise?
- Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
